Evidence map›Paper›PMID 34143291›Full record

ArticleWorld journal of microbiology & biotechnology2021

Distribution of class IId bacteriocin-producing Virgibacillus salexigens in various environments.

Hitomi Omachi, Takeshi Terahara, Kunihiko Futami, Satoshi Kawato, Chiaki Imada, Kaeko Kamei, Tomonori Waku, Akihiro Kondo, Takeshi Naganuma, Tri Winarni Agustini and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Characterization of the Novel Leaderless Bacteriocin, Bawcin, fromInternational journal of molecular sciences · 2023
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Hitomi OmachiGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato, Tokyo, 108-8477, Japan.
Takeshi TeraharaGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato, Tokyo, 108-8477, Japan.
Kunihiko FutamiGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato, Tokyo, 108-8477, Japan.
Satoshi KawatoGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato, Tokyo, 108-8477, Japan.
Chiaki ImadaGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato, Tokyo, 108-8477, Japan.
Kaeko KameiFaculty of Molecular Chemistry and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan.
Tomonori WakuFaculty of Molecular Chemistry and Engineering, Kyoto Institute of Technology, Matsugasaki, Sakyo-ku, Kyoto, 606-8585, Japan.
Akihiro KondoHiyoshi Corporation, 908 Kitanosho, Omihachiman, Shiga, 523-8555, Japan.
Takeshi NaganumaGraduate School of Integrated Sciences for Life, Hiroshima University, 1-4-4 Kagamiyama, Higashi-hiroshima, Hiroshima, 739-8527, Japan.
Tri Winarni AgustiniDepartment of Fisheries Product Technology, Faculty of Fisheries and Marine Science, Diponegoro University, Jl. Prof. H. Soedarto, SH Tembalang, Semarang, 50275, Indonesia.
Takeshi KobayashiGraduate School of Marine Science and Technology, Tokyo University of Marine Science and Technology, 4-5-7 Konan, Minato, Tokyo, 108-8477, Japan. takeshik@kaiyodai.ac.jp.ORCID http://orcid.org/0000-0002-4417-0509
Tokyo University of Marine Science and Technology · JPKyoto Institute of Technology · JPDiponegoro University · IDHiroshima University · JPMiyoshi Kasei (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We performed several experiments using three strains of Virgibacillus salexigens, namely, P2, NT N53, and C-20Mo

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsBacterial ProteinsBacteriocinsEnvironmental MicrobiologyHumansRNA, Ribosomal, 16SSeawaterSequence Analysis, DNAVirgibacillusWhole Genome SequencingAnti-Bacterial AgentsBacterial ProteinsBacteriocinsRNA, Ribosomal, 16SAntibacterial substanceBacteriocinDifferent isolation sourcesVirgibacillus salexigens

Identifiers

PMID34143291
OpenAlexW3167300665

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.